Alberta Confirms Blood Clot Disorder Death Linked to AstraZeneca Vaccine

A vial of the AstraZeneca COVID-19 vaccine is seen with injection supplies at a clinic in Winnipeg, on March 19, 2021. THE CANADIAN PRESS/John Woods

EDMONTON—An Alberta woman in her 50s has died from a rare blood clot disorder after receiving the Oxford-AstraZeneca COVID-19 vaccine.

It is the second reported death from vaccine-induced immune thrombotic thrombocytopenia or VITT linked to the AstraZeneca vaccine in Canada. A 54-year-old Quebec woman died last month.